Label: GUAIFENESIN tablet, extended release

  • NDC Code(s): 58602-811-01, 58602-811-02, 58602-811-03, 58602-811-05, view more
    58602-811-12, 58602-811-21, 58602-811-56, 58602-811-57, 58602-811-60, 58602-811-64, 58602-811-73
  • Packager: Aurohealth LLC
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated November 29, 2023

If you are a consumer or patient please visit this version.

View All Sections
  • Active ingredient

    (in each extended-release tablet)
    Guaifenesin USP 1200 mg

  • Purpose

    Expectorant

  • Uses


    • helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive
  • Warnings


    Do not use

    • for children under 12 years of age
  • Ask a doctor before use if you have


    • persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema
    • cough accompanied by too much phlegm (mucus)
  • Stop use and ask a doctor if


    • cough lasts more than 7 days, comes back, or occurs with fever, rash, or persistent headache. These could be signs of a serious illness.
  • If pregnant or breast-feeding,


    ask a health professional before use.

  • Keep out of reach of children.


    In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

  • Directions

    • do not crush, chew, or break tablet
    • take with a full glass of water
    • this product can be administered without regard for the timing of meals
    • adults and children 12 years of age and over: 1 tablet every 12 hours. Do not exceed 2 tablets in 24 hours.
    • children under 12 years of age: do not use
  • Other information

    • store between 20° to 25°C (68° to 77°F)
  • Inactive ingredients


    colloidal silicon dioxide, hypromellose, magnesium stearate, microcrystalline cellulose, povidone, and pregelatinised starch (maize)

  • Questions?

    1-855-274-4122 (Monday – Friday 8:30 AM to 5:00 PM EST) You may also report side effects to this phone number.


    Distributed by:
    AUROHEALTH LLC.
    279 Princeton-Hightstown Road,
    East Windsor, NJ 08520

    Made in India

    Code: AP/DRUGS/04/2016

  • PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 1200 mg (20 Tablet Label)

    AUROHEALTH
    NDC 58602-811-05
    MAXIMUM STRENGTH

    Guaifenesin
    Extended-Release
    Tablets 1200 mg
    EXPECTORANT

    12
    HOUR

    • Relieves Chest Congestion
    • Thins And Loosens Mucus

    14 
    Extended-Release
    Tablets

    PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 1200 mg (20 Tablet Label) 


  • PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 1200 mg (20 Tablet Carton Label)

    AUROHEALTH

    NDC 58602-811-05

    Compare to the active
    Ingredient in Maximum

    Strength Mucinex®*

    MAXIMUM STRENGTH

    Guaifenesin Extended-Release Tablets 1200 mg
    EXPECTORANT

    • Relieves Chest Congestion
    • Thins And Loosens Mucus

    12
    HOUR
    14

    Extended-Release
    Tablets
     

    PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 1200 mg (20 Tablet Carton Label)


  • PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 1200 mg Blister Carton (14 (1 x 14) Tablets)

    AUROHEALTH

    NDC 58602-811-01

    Compare to the active
    Ingredient in Maximum

    Strength Mucinex®*

    MAXIMUM STRENGTH

    Guaifenesin
    Extended-Release Tablets 1200 mg
    EXPECTORANT

    • Relieves Chest Congestion
    • Thins And Loosens Mucus

    14
    Extended-Release
    Tablets

    12 HOUR


    PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 1200 mg Blister Carton (14 (1 x 14) Tablets)
  • INGREDIENTS AND APPEARANCE
    GUAIFENESIN 
    guaifenesin tablet, extended release
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:58602-811
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    GUAIFENESIN (UNII: 495W7451VQ) (GUAIFENESIN - UNII:495W7451VQ) GUAIFENESIN1200 mg
    Inactive Ingredients
    Ingredient NameStrength
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    HYPROMELLOSE 2208 (15000 MPA.S) (UNII: Z78RG6M2N2)  
    HYPROMELLOSE 2910 (10000 MPA.S) (UNII: 0HO1H52958)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    MICROCRYSTALLINE CELLULOSE 101 (UNII: 7T9FYH5QMK)  
    MICROCRYSTALLINE CELLULOSE 102 (UNII: PNR0YF693Y)  
    POVIDONE K90 (UNII: RDH86HJV5Z)  
    POVIDONE K25 (UNII: K0KQV10C35)  
    STARCH, CORN (UNII: O8232NY3SJ)  
    Product Characteristics
    ColorWHITE (white to off-white) Scoreno score
    ShapeOVALSize21mm
    FlavorImprint Code L;69
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:58602-811-051 in 1 CARTON10/21/2019
    114 in 1 BOTTLE; Type 0: Not a Combination Product
    2NDC:58602-811-731 in 1 CARTON10/21/2019
    220 in 1 BOTTLE; Type 0: Not a Combination Product
    3NDC:58602-811-571 in 1 CARTON10/21/2019
    328 in 1 BOTTLE; Type 0: Not a Combination Product
    4NDC:58602-811-121 in 1 CARTON10/21/2019
    440 in 1 BOTTLE; Type 0: Not a Combination Product
    5NDC:58602-811-601 in 1 CARTON10/21/2019
    542 in 1 BOTTLE; Type 0: Not a Combination Product
    6NDC:58602-811-21100 in 1 BOTTLE; Type 0: Not a Combination Product10/21/2019
    7NDC:58602-811-011 in 1 CARTON10/21/2019
    714 in 1 BLISTER PACK; Type 0: Not a Combination Product
    8NDC:58602-811-022 in 1 CARTON10/21/2019
    814 in 1 BLISTER PACK; Type 0: Not a Combination Product
    9NDC:58602-811-033 in 1 CARTON10/21/2019
    914 in 1 BLISTER PACK; Type 0: Not a Combination Product
    10NDC:58602-811-564 in 1 CARTON01/31/2020
    1014 in 1 BLISTER PACK; Type 0: Not a Combination Product
    11NDC:58602-811-641 in 1 CARTON11/26/2020
    117 in 1 BLISTER PACK; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA21045310/21/2019
    Labeler - Aurohealth LLC (078728447)
    Establishment
    NameAddressID/FEIBusiness Operations
    APL HEALTHCARE LIMITED650918514ANALYSIS(58602-811) , MANUFACTURE(58602-811)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!